James Flounlacker is listed as an executive officer on 2 SEC Form D filings by 1 issuer between Jan 2009 and Feb 2009: REGEN BIOLOGICS INC (Hackensack, NJ — biotechnology — 2009; $7.05M reported sold to 31 investors).
What this means One deal on file with the SEC, filed Feb 2009. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Public records searched: federal courts (CourtListener / RECAP), state securities regulators (AZ, CA, DE, TX, WA) — none found. Not yet searched: SEC enforcement releases.
What this means Nothing turned up where we looked (2 sources). That does not prove there is nothing — it means none was found in those sources on that date.